CLINICAL_TRIALS
trial_result
· 2015-09-28
Clinical Trial Update: A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Malignant Lymphoma (0683-030) [Phase 1]
Summary
This update notes the completion of a Phase 1 trial evaluating oral SAHA (vorinostat) in patients with malignant lymphoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Lymphoma | Phase 1 | Status: COMPLETED